LABORATORIO REIG JOFRE, S.A. «12345...» Página 3 de 54 desde 01/07/1988 hasta 16/07/2024 23/09/2019 18:18 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281952 16/09/2019 12:32 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281759 09/09/2019 11:11 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281585 02/09/2019 22:25 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281423 19/08/2019 22:32 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281261 05/08/2019 15:04 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Número de registro: 281081 29/07/2019 19:20 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre reports the acquisition within the Temporary Share Buy-back Program Número de registro: 280781 25/07/2019 08:38 LABORATORIO REIG JOFRE, S.A. Information on P&L Reig Jofre releases results note of first half of 2019 Número de registro: 280571 22/07/2019 22:03 LABORATORIO REIG JOFRE, S.A. Buy-back programmes, stabilisation and treasury stock Reig Jofre informs on the start of the first Temporary Share Buyback Program Número de registro: 280430 01/07/2019 17:58 LABORATORIO REIG JOFRE, S.A. Strategic agreements with third parties Reig Jofre acquires Bioibérica’s portfolio of finished pharmaceutical and nutraceutical products, representing a turnover of € 26M and establishes a strategic agreement to develop the joint health market Número de registro: 279772 Página 3 de 54 «12345...»
